March 15, 2012
Merck Millipore Launches Mobius® CellReady 50 L Single-use Stirred Tank Bioreactor
March 15, 2012, Darmstadt, Germany - Merck Millipore, the Life Science division of Merck KGaA* of Darmstadt, Germany, today expanded the Mobius® CellReady Bioreactor portfolio with the launch of a 50 L single-use stirred tank bioreactor for process development and pilot scale mammalian cell culture. This new single-use bioreactor allows biopharmaceutical manufacturers to implement robust, single-use technologies that bring their drugs to market faster, with less risk. This single-use bioreactor further demonstrates Merck Millipore’s commitment to support the industry’s focus on implementing complete single-use bioprocess platforms.
- Unique container design enables simple, reliable, and robust installation
- Mobius® SensorReady technology provides unmatched flexibility to monitor and control processes with a variety of conventional and single-use sensor technologies with a standardized bioreactor process container
- Open architecture allows flexibility in the choice of automation platforms
"The Mobius® CellReady 50 L bioreactor is an important addition to the Mobius® family. We’ve integrated a number of innovative features that deliver ease of use, reliability and operational flexibility compared to existing single-use systems," said Paul Chapman, Vice President of Biopharm Process Solutions. "With this introduction, biopharmaceutical manufacturers now have a wider range of scalable single-use bioreactors offered by Merck Millipore, from three liters to two hundred liters, to support their needs from process development to clinical scale."
The Mobius® CellReady 50 L bioreactor extends the company’s portfolio of single-use processing systems from cell culture through ultrafiltration/diafiltration. The innovative Mobius® SensorReady technology offers the ultimate flexibility to configure process monitoring at the point of use, reducing the need to customize bioreactor process containers and enabling easy integration of new sensor technologies. The unique rigid base and top panel design of the bioreactor process container enables simple, reliable and robust installation – improving operator confidence in set up and system operation. The Mobius® CellReady Bioreactor system is available as a turn-key system complete with Finesse automation or as a modular system that can be integrated with a customer’s platform of choice.
Details about the Mobius® CellReady 50 L bioreactor and our complete portfolio of standard single-use systems are available at www.merckmillipore.com/mobius.
About Merck Millipore
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2010 revenues of EUR 1.7 million. Merck Millipore operates as EMD Millipore in the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany.